AIM: TO investigate the safety of adult-to-adult living donor liver transplantation (A-A LDLT) in both donors and recipients. METHODS: From January 2002 to July 2006, 50 cases of A-A LDLT were performed at West Ch...AIM: TO investigate the safety of adult-to-adult living donor liver transplantation (A-A LDLT) in both donors and recipients. METHODS: From January 2002 to July 2006, 50 cases of A-A LDLT were performed at West China Hospital, Sichuan University, consisting of 47 cases using right lobe graft without middle hepatic vein (HHV), and 3 cases using dual grafts (one case using two left lobe, 2 using one right lobe and one left lobe). The most common diagnoses were hepatitis B liver cirrosis, 30 (60%) cases; and hepatocellular carcinoma, 15 (30%) cases in adult recipients. Among them, 10 cases had the model of end-stage liver disease (HELD) with a score of more than 25. Donor screening consisted of reconstruction of the hepatic blood vessels and biliary system with 3-dimension computed tomography and volumetry of whole liver and right liver volume. Various improved surgical techniques were adopted in the procedures for both donors and recipients. RESULTS: Forty-nine right lobes and 3 left lobes (2 left lobe grafts for 1 recipient, 1 left lobe graft for 1 recipient who had received right lobe graft donated by relative living donor) were obtained from 52 living donors. The 49 right lobe grafts, without HHV, weighed 400 g-850 g (media 550 g), and the ratio of graft volume to recipient standard liver volume (GV/SLV) ranged from 31.74% to 71.68% (mean 45.35%). All donors' remnant liver volume was over 35% of the whole liver volume. There was no donor mortality. With a follow- up of 2-52 mo (media 9 too), among 50 adult recipients, complications occurred in 13 (26%) cases and 4 (8%) died postoperatively within 3 mo. Their 1-year actual survival rate was 92%.CONCLUSION: When preoperative CT volumetry shows volume of remnant liver is more than 350, the ratio of right lobe graft to recipients standard liver volume exceeding 40%, A-A LDLT using right lobe graft without MHV should be a very safe procedure for both donors and recipients, otherwise dual grafts liver transplantation should be considered.展开更多
In 2011,the Chinese Academy of Sciences launched an engineering project to develop an acceleratordriven subcritical system(ADS)for nuclear waste transmutation.The China Lead-based Reactor(CLEAR),proposed by the Instit...In 2011,the Chinese Academy of Sciences launched an engineering project to develop an acceleratordriven subcritical system(ADS)for nuclear waste transmutation.The China Lead-based Reactor(CLEAR),proposed by the Institute of Nuclear Energy Safety Technology,was selected as the reference reactor for ADS development,as well as for the technology development of the Generation IV lead-cooled fast reactor.The conceptual design of CLEAR-I with 10 MW thermal power has been completed.KYLIN series lead-bismuth eutectic experimental loops have been constructed to investigate the technologies of the coolant,key components,structural materials,fuel assembly,operation,and control.In order to validate and test the key components and integrated operating technology of the lead-based reactor,the lead alloy-cooled non-nuclear reactor CLEAR-S,the lead-based zero-power nuclear reactor CLEAR-0,and the lead-based virtual reactor CLEAR-V are under realization.展开更多
文摘AIM: TO investigate the safety of adult-to-adult living donor liver transplantation (A-A LDLT) in both donors and recipients. METHODS: From January 2002 to July 2006, 50 cases of A-A LDLT were performed at West China Hospital, Sichuan University, consisting of 47 cases using right lobe graft without middle hepatic vein (HHV), and 3 cases using dual grafts (one case using two left lobe, 2 using one right lobe and one left lobe). The most common diagnoses were hepatitis B liver cirrosis, 30 (60%) cases; and hepatocellular carcinoma, 15 (30%) cases in adult recipients. Among them, 10 cases had the model of end-stage liver disease (HELD) with a score of more than 25. Donor screening consisted of reconstruction of the hepatic blood vessels and biliary system with 3-dimension computed tomography and volumetry of whole liver and right liver volume. Various improved surgical techniques were adopted in the procedures for both donors and recipients. RESULTS: Forty-nine right lobes and 3 left lobes (2 left lobe grafts for 1 recipient, 1 left lobe graft for 1 recipient who had received right lobe graft donated by relative living donor) were obtained from 52 living donors. The 49 right lobe grafts, without HHV, weighed 400 g-850 g (media 550 g), and the ratio of graft volume to recipient standard liver volume (GV/SLV) ranged from 31.74% to 71.68% (mean 45.35%). All donors' remnant liver volume was over 35% of the whole liver volume. There was no donor mortality. With a follow- up of 2-52 mo (media 9 too), among 50 adult recipients, complications occurred in 13 (26%) cases and 4 (8%) died postoperatively within 3 mo. Their 1-year actual survival rate was 92%.CONCLUSION: When preoperative CT volumetry shows volume of remnant liver is more than 350, the ratio of right lobe graft to recipients standard liver volume exceeding 40%, A-A LDLT using right lobe graft without MHV should be a very safe procedure for both donors and recipients, otherwise dual grafts liver transplantation should be considered.
文摘In 2011,the Chinese Academy of Sciences launched an engineering project to develop an acceleratordriven subcritical system(ADS)for nuclear waste transmutation.The China Lead-based Reactor(CLEAR),proposed by the Institute of Nuclear Energy Safety Technology,was selected as the reference reactor for ADS development,as well as for the technology development of the Generation IV lead-cooled fast reactor.The conceptual design of CLEAR-I with 10 MW thermal power has been completed.KYLIN series lead-bismuth eutectic experimental loops have been constructed to investigate the technologies of the coolant,key components,structural materials,fuel assembly,operation,and control.In order to validate and test the key components and integrated operating technology of the lead-based reactor,the lead alloy-cooled non-nuclear reactor CLEAR-S,the lead-based zero-power nuclear reactor CLEAR-0,and the lead-based virtual reactor CLEAR-V are under realization.